Stay updated with breaking news from Vatel Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On December 12, 2023, Vatel Capital, a simplified joint-stock company acting on behalf of the Vatel Remploi fund it manages, declared that it had exceeded the thresholds of 5% of the capital and...
Novo Nordisk A/S and BIOCORP Production SA announced on June 5 that Novo Nordisk has entered into exclusive negotiations for a controlling stake in BIOCORP, which would be followed by a mandatory simplified tender offer on all remaining outstanding shares in BIOCORP1 at a price of 35.00 Euros per share in cash, representing a total equity value of approximately 154 million Euros.
Novo Nordisk has entered into exclusive negotiations with BIO JAG, BIOCORP's main shareholder, for the purchase of its entire stake in BIOCORP, representing 45.3% of its share capital and 62.19%
Novo Nordisk has entered into exclusive negotiations with BIO JAG, BIOCORP’s main shareholder, for the purchase of its entire stake in BIOCORP,...
Novo Nordisk has entered into exclusive negotiations with BIO JAG, BIOCORP’s main shareholder, for the purchase of its entire stake in BIOCORP, representing 45.3% of its share capital and 62.19% of its theoretical voting rights, at a price of 35.00 Euros per share.Certain minority shareholders, representing 19,0% of...